Publications in collaboration with researchers from Instituto de Investigación Sanitaria Biobizkaia (1)

2024

  1. Twice weekly dosing with Sebelipase alfa (Kanuma®) rescues severely ill infants with Wolman disease

    Orphanet Journal of Rare Diseases, Vol. 19, Núm. 1